NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 22 filers reported holding NEUROBO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 76 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 76 | -22.4% | 0.00% | – |
| Q4 2021 | $0 | – | 98 | -30.5% | 0.00% | – |
| Q3 2021 | $0 | – | 141 | -24.6% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 187 | -72.1% | 0.00% | – |
| Q1 2021 | $2,000 | -88.2% | 670 | -79.7% | 0.00% | – |
| Q4 2020 | $17,000 | +750.0% | 3,296 | +550.1% | 0.00% | – |
| Q3 2020 | $2,000 | -83.3% | 507 | -63.8% | 0.00% | – |
| Q2 2020 | $12,000 | +50.0% | 1,399 | +140.4% | 0.00% | – |
| Q1 2020 | $8,000 | +700.0% | 582 | +665.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 93,376 | $45,000 | 0.03% |
| Murchinson Ltd. | 205,256 | $98,000 | 0.02% |
| Mount Yale Investment Advisors, LLC | 57,425 | $28,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 40,496 | $19,000 | 0.00% |
| UBS Group AG | 3,066 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 240 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 356 | $0 | 0.00% |
| NORTHERN TRUST CORP | 17,155 | $8,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 438 | $0 | 0.00% |